New England Science Symposium - NESS
The 2023 New England Science Symposium (NESS) is now accepting abstract submissions!
Please click here to submit your research.Deadline to submit submissions: Friday, January 6th, 2023
The 22nd Annual New England Science Symposium (NESS) will take place in person on Sunday, April 2, 2023 at the Harvard Medical School Joseph B. Martin Conference Center located at 77 Avenue Louis Pasteur in Boston, Massachusetts.
PURPOSE
The New England Science Symposium (NESS), established in 2002, provides a forum for postdoctoral fellows; medical, dental and graduate students; post-baccalaureates; college and community college students (particularly for African-American, Hispanic/Latino and American Indian/Alaska Native individuals) to share their biomedical and health-related research activities through oral or poster presentations, to engage in discussions related to career development in the sciences, to exchange ideas and to expand their professional networks.
ABSTRACT SUBMISSION
Abstract submission portal is now live! Students/fellows may now submit abstracts for presentation consideration. Please click here to submit your research.
ABSTRACT FEEDBACK SESSION - December 3, 2022 (11 AM to 12:30 PM EST)
This virtual session is designed for individuals who wish to receive feedback on their abstract from advisors and peers before submitting it to NESS. The meeting will be set-up in small groups (5-7 individuals) where students will give an elevator pitch not exceeding four minutes long to the group.
***Participating in this session is not required, nor does it guarantee acceptance.
Please click here to submit your abstract to attend the review session. (Please have your ABSTRACT ready BEFORE beginning the application.).
Deadline to Register: Wednesday, November 16, 2022
REGISTRATION
Registration for the general public is now open. Please click here to register.
KEYNOTE SPEAKER
Andrew Plump, M.D., Ph.D
President, Research & Development
Takeda
AGENDA
FLYER
FAQ
Please click here for frequently asked questions. 
If you have any questions or concerns, please email Rodolfo Ramos at rodolfo_ramos@hms.harvard.edu
PRESENTATION RESOURCES (Videos)
- Introduction on the Beginning Stages of Creating a Poster
- Getting Started on Creating a Poster (Format, Templates and Softwares)
- Transferring Your Abstract into a Poster (Step by Step Guide)
- How to Present Your Poster and Practice Your Presentation
- Poster Presentation Outline (Summary)
Additional Resources
How To Make Great Online Presentations In The Virtual Era
Guidance and Tips on Writing an Abstract
AWARDS
Awards for outstanding oral and poster presentations in various disciplines and categories are: Ruth and William Silen, M.D. Awards, Dana-Farber/Harvard Cancer Center Awards, Postdoctoral Awards sponsored by Vertex, Beth Israel Deaconess Medical Center Department of Neonatology Award, TACS BIO Stem Cell and Regenerative Medicine Award, American Cancer Society Awards, and Predicine Translational Research Award.
For description of the awards and list of award winners, please click here.
SPONSORS
Harvard Medical School
Minority Faculty Development Program (MFDP)
The Minority Faculty Development Program (Established 1990) of the Office for Diversity Inclusion and Community Partnership (Established 2002; originally named Faculty Development and Diversity) sponsors programs for the development of Harvard Medical School faculty and trainees, with an emphasis on mentoring and leadership, as well as programs that are designed to reach out to the pre-college, college, graduate and postdoctoral populations with the goal of bringing outstanding students from groups underrepresented in medicine into the biomedical science pipeline.
BSCP was founded in 1991 by MFDP in collaboration with the Massachusetts Medical Society and the New England Board of Higher Education to identify, inform, support and provide mentoring for academically outstanding minority students and fellows ranging from high school to postdoctoral level.
SUPPORTER
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
